Clinical Trial Update: Safe Zone in Trigger Point Injection

View source ↗

Summary

A clinical trial from Ankara University is assessing a 'Safe Zone' approach for trigger point injections, currently recruiting for myofascial pain conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myofascial Pain Syndrome

Snippet

Sponsor: Ankara University | Conditions: Trigger Point Pain, Myofascial | Status: RECRUITING